Suchergebnisse - "Breast Cancer Expert Committee of National Cancer Quality Control Center"

PubPharm (11)

1

Guideline for the management path and quality control of breast cancer prevention and treatment in China's counties (2023 edition)

enthalten in: Zhonghua zhong liu za zhi [Chinese journal of oncology | 2024

von Breast Cancer Expert Committee of National Cancer Quality Control Center | Cancer Prevention and Treatment Committee of Healthy China Research Center

2

Expert consensus on the clinical application of antibody drug conjugates in the treatment of malignant tumors (2023 edition)

enthalten in: Zhonghua zhong liu za zhi [Chinese journal of oncology | 2023

von Professional Committee on Clinical Research of Oncology Drugs, C. | Expert Committee for Monitoring the Clinical Application of Antitumor Drugs; | Breast Cancer Expert Committee of National Cancer Quality Control Center; | +1

3

Guidelines for clinical diagnosis and treatment of advanced breast cancer in China (2022 edition)

enthalten in: Zhonghua zhong liu za zhi [Chinese journal of oncology | 2022

von Breast Cancer Expert Committee of National Cancer Quality Control Center | Breast Cancer Expert Committee of China Anti-Cancer Association | Cancer Drug Clinical Research Committee of China Anti-Cancer Association

4

Expert consensus on the clinical application of antibody-drug conjugates in the treatment of malignant tumors (2021 edition)

enthalten in: Cancer innovation | 2022

von Professional Committee on Clinical Research of Oncology Drugs, C. | Expert Committee for Monitoring the Clinical Application of Antitumor Drugs | Breast Cancer Expert Committee of National Cancer Quality Control Center | +1

5

Expert consensus on the clinical application of PI3K/AKT/mTOR inhibitors in the treatment of advanced breast cancer

enthalten in: Cancer innovation | 2022

von Society of Clinical Research of Oncology Medications of China Anticancer Association | Breast Cancer Expert Committee of National Cancer Quality Control Center | Boao Cancer Innovation Institute

6

Quality control index for standardized diagnosis and treatment of breast cancer in China (2022 Edition)

enthalten in: Zhonghua zhong liu za zhi [Chinese journal of oncology | 2022

von Breast Cancer Expert Committee of National Cancer Quality Control Center

7

Comprehensive management guideline for breast cancer follow-up and healthcare (2022 edition)

enthalten in: Zhonghua zhong liu za zhi [Chinese journal of oncology | 2022

von Breast Cancer Expert Committee of National Cancer Quality Control Center | Health Management Professional Committee of Beijing Breast Cancer Prevention and Control Society

8

Expert consensus on the clinical application of antibody‐drug conjugates in the treatment of malignant tumors (2021 edition)

in: Cancer Innovation | 2022

von Professional Committee on Clinical Research of Oncology Drugs, C. | Expert Committee for Monitoring the Clinical Application of Antitumor Drugs | Breast Cancer Expert Committee of National Cancer Quality Control Center | +1

9

Consensus recommendations for the clinical application of CDK4/6 inhibitors in patients with hormone receptor positive, human epidermal growth factor receptor 2 negative advanced breast cancer

enthalten in: Zhonghua zhong liu za zhi [Chinese journal of oncology | 2021

von Breast Cancer Expert Committee of National Cancer Quality Control Center | Cancer Drug Clinical Research Committee of China Anti-Cancer Association

10

Expert consensus on the clinical application of antibody drug conjugates in the treatment of malignant tumors (2020 Edition)

enthalten in: Zhonghua zhong liu za zhi [Chinese journal of oncology | 2021

von Professional Committee on Clinical Research of Oncology Drugs, C. | Expert Committee for Monitoring the Clinical Application of Antitumor Drugs | Breast Cancer Expert Committee of National Cancer Quality Control Center | +1